Xultophy®
-
Xultophy® reported a better option than basal-bolus insulin therapy to manage type 2 diabetes
Dec 6, 2017Once-daily Xultophy® (insulin degludec/liraglutide) was a better option to manage diabetes compared to multiple daily injections of insulin (basal-bolus regimen). This was reported by people with type 2 diabetes whose blood sugar was not controlled on...